ADVERTISEMENT

France suspends marketing authorisation for migraine and HIV drugs

Heather Mason   |   Medical News   |   23 January 2023
ADVERTISEMENT

As of 5 January 2023, the French health authority, Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM), has suspended marketing authorisations for two drugs in accordance with an earlier decision by the European Medicines Agency (EMA). The drugs are Zolmitriptan Mylan (2.5 mg orodispersible or film-coated...

          

Topic Challenges

left
right